MicrobeWorld App


Microbes After Hours


Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email


Featured Image

Featured Video

Ebola Virus explained


ASM House 200X200

Synthetic Biology Delivers Cool Tools but New Therapeutics Are a Ways Off

What does it take to transform a microbe normally found in the intestinal tract into a cancer-killing machine? These and other questions about the applicability of synthetic biology abound. For cancer research in particular, the field of syn bio could both reveal new insights into the disease and potentially lead to new treatments.

Despite exciting developments in synthetic biology, however, whether the NIH will found and dedicate a specific new program to this field remains to be seen. NCI and the National Institute of General Medical Sciences held a workshop in April 2010 with an eye toward understanding the opportunities for biomedical research in synthetic biology, J. Jerry Li, M.D., Ph.D., Division of Cancer Biology program director, told GEN.

“We invited program managers from other agencies including the National Science Foundation and the Department of Energy. As of 2010, those agencies had dedicated programs to support synthetic biology but NIH as a whole did not,” he remarked. “We asked ourselves whether it was time to put together a synthetic biology centric program.”

NIH held the workshop because recent advances in synthetic biology had created a receptive, anticipatory climate for this new field, Dr. Li added. J. Craig Venter, Ph.D., published work on the first synthetic bacterial genome, and the FDA had just approved Artemisinin, an antimalaria drug produced using engineered bacteria and yeast.

Comments (0)

Collections (0)


American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use